Merck reported EUR15.14B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Adidas EUR 13.19B 364M Sep/2026
Adyen EUR 13.97B 2.28B Jun/2026
Akzo Nobel EUR 8.41B 287M Sep/2026
Alcon AG USD 6.62B 4M Jun/2026
Amadeus IT EUR 2.64B 5.6M Sep/2026
Amarin USD 612.88M 10.12M Sep/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
BASF EUR 35.21B 3.58B Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Beiersdorf EUR 7.43B 768M Jun/2026
Covestro EUR 6.18B 271M Jun/2026
Danone EUR 16.06B 2.83B Jun/2026
Fresenius EUR 12.29B 678M Sep/2026
Fresenius Medical Care EUR 7.84B 150.6M Sep/2026
Genmab DKK 2.8B 228M Jun/2026
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.9B 336M Sep/2026
GRIFOLS EUR 5.35B 40M Sep/2026
Henkel EUR 11.93B 1.86B Jun/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Infineon EUR 11.25B 960M Sep/2026
Lakefront Biotherapeutics EUR 2.31B 751.38M Jun/2026
Linde USD 13.42B 665M Sep/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 15.14B 1.37B Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Philips EUR 10.51B 1.18B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 33.21B 1.68B Sep/2026
UCB EUR 6.05B 733M Dec/2025